AbbVie | ABBV - Créanciers Commerciaux

Prix De L'Action
198.71
Variation Quotidienne
-2.24 -1.11%
Mensuellement
-4.09%
Annuel
6.80%
Q2 Prévisions
194.46




Créanciers Commerciaux Changement Date
AbbVie USD 3.59B 28.65B 2025-12
Abbott USD 4.24B 117M 2025-12
ALKERMES USD 107.95M 39.95M 2025-12
Amgen USD 20.89B 1.25B 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Coherus Biosciences USD 9.91M 14.98M 2025-12
Eisai JPY 85.49B 4.76B 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Gilead Sciences USD 715M 93M 2025-12
GlaxoSmithKline GBP 15.38B 294M 2025-12
Infinity Pharmaceuticals USD 1.5M 433K 2023-06
J&J USD 10.46B 1.53B 2026-03
Medtronic USD 2.57B 12M 2025-12
Merck USD 4.15B 102M 2025-09
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novartis USD 4.46B 99M 2025-12
Pacira USD 15.15M 2.54M 2025-12
Perrigo USD 474.5M 4.8M 2025-12
Pfizer USD 5.02B 142M 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
UCB EUR 4.04B 755M 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
United Therapeutics USD 7.1M 460.9M 2025-12
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12
Zoetis USD 487M 77M 2025-12